Get informed when a big investor buys or sells
+ FollowOvervalued by 74.5% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $18.95 Billion |
|---|---|
| Enterprise Value | $19.08 Billion |
| Annual dividend | $0.13 |
| Dividend yield | 1.03% |
| Earnings per Share | $0.21 |
| Beta | 1.38 |
| Outstanding Shares | 1,590,102,180 |
| P/E Ratio | 41.81 |
|---|---|
| PEG | 769.44 |
| Price to Sales | 3.93 |
| Price to Book Ratio | 11.79 |
| Enterprise Value to Revenue | 3.66 |
| Enterprise Value to EBIT | 11.89 |
| Enterprise Value to Net Income | 24 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.22 |
No data
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 0.02%▲ 0.00% |
|---|---|
| Total Invested | $4.24M▲ 30.15% |
| Investors Holding | 7▼ 1.00% |
Straumann Holding AG engages in the provision of implant, restorative, and regenerative dentistry solutions to dental professionals and laboratories. It operates through the following segments: Sales Europe, Sales Distributor & Emerging ...